Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Hansyn Pharmaceutical is a China-based pharmaceutical manufacturing company focused on small-molecule active pharmaceutical ingredients, intermediates, veterinary APIs, and related custom research and manufacturing services. The company operates a manufacturing site in Zhangjiagang, Jiangsu, and an R&D and business center in Shanghai, serving regulated sourcing, contract research and development, and cGMP custom manufacturing needs for pharmaceutical customers. Public-facing materials indicate capabilities spanning process development, analytical development, scale-up, pilot production, and commercial manufacturing. Hansyn markets products including posaconazole, efinaconazole, florfenicol, and prasugrel hydrochloride intermediates/APIs, and describes therapeutic focus areas including respiratory, cardiovascular, metabolism, diabetes, and animal health. The business appears to be a private, active pharma supplier and service provider rather than a clinical-stage drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Hansyn Pharmaceutical.